Chen J, Lipska BK, Weinberger DR (2006) Genetic mouse models of schizophrenia: from hypothesis-based to susceptibility gene-based models. Biol Psychiatry 59:1180-1188PubMedCrossRef

O’Tuathaigh CMP, Babovic D, O’Meara G et al (2007) Susceptibility genes for schizophrenia: phenotypic characterisation of mutant models. Neurosci Biobehav Rev 31:60-78PubMedCrossRef

Desbonnet L, Waddington JL, O’Tuathaigh CM (2009) Mutant models for genes associated with schizophrenia. Biochem Soc Trans 37:308-312PubMedCrossRef

Desbonnet L, Waddington JL, O’Tuathaigh CM (2009) Mice mutant for genes associated with schizophrenia: common phenotype or distinct endophenotypes? Brain Behav Res, (in press)

Tandon R, Nasrallah HA, Keshavan MS (2009) Schizophrenia, “just the facts”: Part 4: Clinical features and conceptualization. Schizophr Res, (in press)

Bocti C, Black DN, Waddington JL (2004) Dyskinesia in patients with schizophrenia never treated with antipsychotics: conceptual and pathophysiological implications. In: Bedard MA (ed) Mental and behavioural dysfunction in movement disorders. Humana Press, Totawa, NJ, pp 489-498

Tomiyama K, O’Tuathaigh CM, O’Sullivan GJ et al (2009) Phenotype of spontaneous orofacial dyskinesia in neuregulin-1 “knockout” mice. Prog Neuropsychopharmacol Biol Psychiatry 33:330-333PubMedCrossRef

Whitty PF, Owoeye O, Waddington JL (2009) Neurological signs and involuntary movements in schizophrenia: intrinsic to and informative on systems pathobiology. Schizophr Bull 35:415-424PubMedCrossRef

Waddington JL, Morgan MG (2001) Pathobiology of schizophrenia. In: Lieberman JA, Murray RM (eds) Comprehensive care of schizophrenia. Martin Dunitz, London, pp 28-35

Gogos JA (2007) Schizophrenia susceptibility genes: in search of a molecular logic and novel drug targets for a devastating disorder. Int Rev Neurobiol 78:397-422PubMedCrossRef

Allen NC, Bagade S, McQueen MB et al (2008) Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat Genet 40:827-834PubMedCrossRef

Shi J, Gershon ES, Liu C (2008) Genetic associations with schizophrenia: Meta-analyses of 12 candidate genes. Schizophr Res 104:96-107PubMedCrossRef

Gavériaux-Ruff C, Kieffer BL (2007) Condi­tional gene targeting in the mouse nervous system: Insights into brain function and diseases. Pharmacol Ther 113:619-634PubMedCrossRef

O’Neal KR, Agah R (2007) Conditional targeting: inducible deletion by Cre recombinase. Methods Mol Biol 366:309-320PubMedCrossRef

Crawley JN (2008) Behavioral phenotyping strategies for mutant mice. Neuron 57:809-818PubMedCrossRef

Low NC, Hardy J (2007) What is a schizophrenic mouse? Neuron 54:348-349PubMedCrossRef

Tecott LH, Nestler EJ (2004) Neurobehavioral assessment in the information age. Nat Neurosci 7:462-466PubMedCrossRef

Waddington JL, O’Tuathaigh C, O’Sullivan G et al (2005) Phenotypic studies on dopamine receptor subtype and associated signal transduction mutants: insights and challenges from 10   years at the psychopharmacology-molecular biology interface. Psychopharmacology 181:611-638PubMedCrossRef

O’Tuathaigh CM, O’Sullivan GJ, Kinsella A et al (2006) Sexually dimorphic changes in the exploratory and habituation profiles of heterozygous neuregulin-1 knockout mice. NeuroReport 17:79-83PubMedCrossRef

Babovic D, O’Tuathaigh CM, O’Sullivan GJ et al (2007) Exploratory and habituation phenotype of heterozygous and homozygous COMT knockout mice. Behav Brain Res 183:236-239PubMedCrossRef

Moy SS, Nadler JJ, Perez A et al (2004) Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice. Genes Brain Behav 3:287-302PubMedCrossRef

O’Tuathaigh CM, Babovic D, O’Sullivan GJ et al (2007) Phenotypic characterization of spatial cognition and social behavior in mice with ‘knockout’ of the schizophrenia risk gene neuregulin 1. Neuroscience 147:18-27PubMedCrossRef

Babovic D, O’Tuathaigh CM, O’Connor AM et al (2008) Phenotypic characterization of cognition and social behavior in mice with heterozygous versus homozygous deletion of catechol-O-methyltransferase. Neuroscience 155:1021-1029PubMedCrossRef

Guillin O, Abi-Dargham A, Laruelle M (2007) Neurobiology of dopamine in schizophrenia. Int Rev Neurobiol 78:1-39PubMedCrossRef

Goldman-Rakic PS (1998) The cortical dopamine system: role in memory and cognition. Adv Pharmacol 42:707-711PubMedCrossRef

Mattay VS, Goldberg TE, Fera F et al (2003) Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci USA 100:6186-6191PubMedCrossRef

Vijayraghavan S, Wang M, Birnbaum SG et al (2007) Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory. Nat Neurosci 10:376-384PubMedCrossRef

Coyle JT (2006) Glutamate and schizophrenia: beyond the dopamine hypothesis. Cell Mol Neurobiol 26:365-384PubMedCrossRef

Stone JM, Morrison PD, Pilowsky LS (2007) Glutamate and dopamine dysregulation in schizophrenia-a synthesis and selective review. J Psychopharmacol 21:440-452PubMedCrossRef

Pilowsky LS, Bressan RA, Stone JM et al (2006) First in vivo evidence of an NMDA receptor deficit in medication-free schizophrenic patients. Mol Psychiatry 11:118-119PubMedCrossRef

Castner SA, Williams GV (2007) Tuning the engine of cognition: a focus on NMDA/D1 receptor interactions in prefrontal cortex. Brain Cogn 63:94-122PubMedCrossRef

Bertram L (2008) Genetic research in schizophrenia: new tools and future perspectives. Schizophr Bull 34:806-812PubMedCrossRef

Chubb JE, Bradshaw NJ, Soares DC et al (2008) The DISC locus in psychiatric illness. Mol Psychiatry 13:36-64PubMedCrossRef

Muir WJ, Pickard BS, Blackwood DH (2008) Disrupted-in-schizophrenia-1. Curr Psychiatry Rep 10:140-147PubMedCrossRef

Gottesman II, Gould TD (2003) The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 160:636-645PubMedCrossRef

Braff DL, Freedman R, Schork NJ et al (2007) Deconstructing schizophrenia: an overview of the use of endophenotypes in order to understand a complex disorder. Schizophr Bull 33:21-32PubMedCrossRef

Kellendonk C, Simpson EH, Polan HJ et al (2006) Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning. Neuron 49:603-615PubMedCrossRef

Drew MR, Simpson EH, Kellendonk C et al (2007) Transient overexpression of striatal D2 receptors impairs operant motivation and interval timing. J Neurosci 27:7731-7739PubMedCrossRef

Bach ME, Simpson EH, Kahn L et al (2008) Transient and selective overexpression of D2 receptors in the striatum causes persistent deficits in conditional associative learning. Proc Natl Acad Sci USA 105:16027-16032PubMedCrossRef

Waddington JL, Clifford JJ, McNamara FN et al (2001) The psychopharmacology-molecular biology interface: exploring the behavioural roles of dopamine receptor subtypes using targeted gene deletion (‘knockout’). Prog Neuropsychopharmacol Biol Psychiatry 25:925-964PubMedCrossRef

O’Sullivan GJ, O’Tuathaigh CM, Tomiyama K, et al. Dopamine receptors and behaviour: From psychopharmacology to mutant models. In: Neve KA, ed. The dopamine receptors. New Jersey: Humana Press, 2009 (in press).

Tomiyama K, McNamara FN, Clifford JJ et al (2002) Phenotypic resolution of spontaneous and D1-like agonist-induced orofacial movement topographies in congenic dopamine D1A receptor ‘knockout’ mice. Neuropharmacology 42:644-652PubMedCrossRef

Tomiyama K, McNamara FN, Clifford JJ et al (2004) Phenotypic resolution of spontaneous and D1-like agonist-induced orofacial movement topographies in congenic dopamine D1A receptor ‘knockout’ mice. Synapse 51:71-81PubMedCrossRef

Tomiyama K, Makihara Y, Yamamoto H et al (2006) Disruption of orofacial movement topographies in congenic mutants with dopamine D5 but not D4 receptor or DARPP-32 transduction ‘knockout’. Eur Neuropsychopharmacol 16:437-445PubMedCrossRef

Gainetdinov RR, Jones SR, Fumagalli F et al (1998) Re-evaluation of the role of the dopamine transporter in dopamine system homeostasis. Brain Res Rev 26:148-153PubMedCrossRef

Hoffman BJ, Hansson SR, Mezey E et al (1998) Localization and dynamic regulation of biogenic amine transporters in the mammalian central nervous system. Front Neuroendocrinol 19:187-231PubMedCrossRef

Gainetdinov RR, Jones SR, Caron MG (1999) Functional hyperdopaminergia in dopamine transporter knock-out mice. Biol Psychiatry 46:303-311PubMedCrossRef

Ralph RJ, Paulus MP, Fumagalli F et al (2001) Prepulse inhibition deficits and perseverative motor patterns in dopamine transporter knock-out mice: differential effects of D1 and D2 receptor antagonists. J Neurosci 21:305-313PubMed